NDC Package 70771-1598-6 Oseltamivir Phosphate

Oseltamivir Acid Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70771-1598-6
Package Description:
60 mL in 1 BOTTLE
Product Code:
Proprietary Name:
Oseltamivir Phosphate
Non-Proprietary Name:
Oseltamivir Acid
Substance Name:
Oseltamivir Phosphate
Usage Information:
Oseltamivir is used to treat symptoms caused by the flu virus (influenza). It helps make the symptoms (such as stuffy nose, cough, sore throat, fever/chills, aches, tiredness) less severe and shortens the recovery time by 1-2 days. This medication may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. (See also Notes section.)
11-Digit NDC Billing Format:
70771159806
NDC to RxNorm Crosswalk:
  • RxCUI: 1115698 - oseltamivir phosphate 6 MG in 1 mL Oral Suspension
  • RxCUI: 1115698 - oseltamivir 6 MG/ML Oral Suspension
  • RxCUI: 1115698 - oseltamivir (as oseltamivir phosphate) 6 MG/ML Oral Suspension
  • RxCUI: 1115698 - oseltamivir phosphate 6 MG per 1 ML Oral Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Cadila Healthcare Limited
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA209113
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-05-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70771-1598-6?

    The NDC Packaged Code 70771-1598-6 is assigned to a package of 60 ml in 1 bottle of Oseltamivir Phosphate, a human prescription drug labeled by Cadila Healthcare Limited. The product's dosage form is suspension and is administered via oral form.

    Is NDC 70771-1598 included in the NDC Directory?

    Yes, Oseltamivir Phosphate with product code 70771-1598 is active and included in the NDC Directory. The product was first marketed by Cadila Healthcare Limited on August 05, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70771-1598-6?

    The 11-digit format is 70771159806. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-170771-1598-65-4-270771-1598-06